Lenti p24 Xpress Assay
Beta Tester Sign Up
If you are still relying on ELISA for lentivirus quantification, you know that traditional assays take time, require multiple hands-on steps, and can delay your workflow.
We’re developing a microfluidic-based immunoassay for the quantification of lentiviral p24 protein from crude and purified samples, delivering results in less than 25 minutes.
Be Among the First to Test the Fast and Automated Lentivirus p24 Quantification. Beta testing is expected to begin around Spring 2026.
Apply as a Beta Tester
Test Our Solution: A Faster, Automated Way to Measure p24
Our microfluidic-based immunoassay combines the sandwich ELISA principle with automation to deliver reliable results in less than 25 minutes. It’s designed for both in-process monitoring and final quality control of lentiviral vector products.
Key Benefits:
• Less than 25 minutes per run, faster than traditional ELISA
• Automated workflow: less manual work, more reproducibility
• Works with crude or purified samples
• Suitable for in-process control and final quality control
Who We’re Looking For
We’re seeking beta testers from:
• CROs and CDMOs (e.g. vector manufacturer)
• Biotech and pharma companies with lentivirus pipelines
• QC and production teams working with lentiviral vectors
Limited availability. Join our beta program today and help us bring faster lentiviral quantification to the field.
Apply as a Beta Tester